Stereotactic ablative radiotherapy and immunotherapy for early-stage lung cancer - Authors' reply. Chang JY, Verma V, Heymach JV. Lancet 2024;404:241-242.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chang JY, Verma V, Heymach JV. Stereotactic ablative radiotherapy and immunotherapy for early-stage lung cancer - Authors' reply. Lancet 2024;404:241-242.
PMID: 39033005